Joint Clinical Trials Office

You are here

News

Olivier Elemento

Here's how virtual reality could help doctors treat cancer

Virtual reality headsets are not yet commonplace, but they already have the potential to revolutionize many aspects of our lives—how we view entertainment like movies and video games, how we see the world, and even how we do science.

Now researchers at Weill Cornell Medicine in New York City have started using the technology to better understand the genetic mutations that drive cancer. They've developed a new program for the Oculus Rift VR headset that lets users see and interact with...

Read More
Dr. Laurie H. Glimcher Stephen and Suzanne Weiss Dean of Weill Cornell Medical College & Provost for Medical Affairs, Cornell University

Among keys to curing cancer, academic medical centers loom large

The moonshot to cure cancer will need to enlist the nation’s academic medical centers, our most powerful incubators of medical innovation. These institutions are already developing – and putting into use –some of the most promising therapies.

Following a memorable State of the Union in which he charged Vice President Joe Biden to lead a “moonshot” to find a cure for cancer, President Obama is proposing nearly $1 billion to fund cancer research over the next two years. The moonshot...

Read More
An investigational drug (AC261066) given to mice with diabetes restores normal blood sugar levels, effectively treating the disease Image credit: Gudas Lab

Experimental Therapy Could Treat Diabetes and Fatty Liver

A new investigational therapy could be a major breakthrough in the treatment of both diabetes and fatty liver, according to Weill Cornell Medicine investigators.

Diabetes is a disease in which the pancreas either does not produce enough insulin or cells in the body fail to respond to insulin properly. Diabetic patients experience abnormally high blood sugar levels, which can lead to heart disease, stroke, kidney failure, and eye damage. The disease, which...

Read More
Dr. Silvia Formenti
Dr. Silvia Formenti

From foe to friend: Transforming tumors into personalized vaccines

Radiation has long been a pillar of cancer care, alongside surgery and chemotherapy. But what if it could be used in a new way - to trigger a set of immune responses that transform tumors into killing machines, a type of in situ vaccine?

Silvia Formenti, M.D., has re-visited radiation as a tool that turns tumor from foe to friend. She uses it to help activate the immune system...

Read More

Researcher's Toolbox

Contact Information

Joint Clinical Trials Office Weill Cornell Medicine /
NewYork-Presbyterian
1300 York Avenue,
Box 305
New York, NY 10065 Phone: (646) 962-8215 Fax: (646) 962-0536

Abbreviation Library